AbbVie (NYSE: ABBV) stock rose 4.2% after the drugmaker forecast 2025 profit above estimates, as strong sales of its newer ...

Investing.com -- U.S. President Donald Trump is anticipated to reveal new tariffs on Canadian and Mexican imports, according to a Friday report by Reuters. These tariffs are slated to become effective ...

Investing.com -- Maze Therapeutics, a clinical-stage biopharmaceutical company, launched its initial public offering (IPO) today, with shares starting to trade at $16.12. The company priced 8,750,000 ...